Thus, these results suggest that TPS240 reduced the expression of CCL17 and CCL22, which are Th2-responsive AD-specific chemokines induced by TNF-α/IFN-γ in human keratinocyte cell lines. This evidence concerns the gene TNF and Alzheimer disease.